Lipha PowerPoint PPT Presentations

Show:

Sort by:

Lipha Pharmaceuticals, Inc. PowerPoint PPT Presentation

Lipha Pharmaceuticals, Inc. - Title: Sample Presentation Subject: FDA Advisory Meeting Author: Maureen Galie Last modified by: John Hornyak Created Date: 5/28/1995 4:20:00 PM Document presentation ...

Title: Sample Presentation Subject: FDA Advisory Meeting Author: Maureen Galie Last modified by: John Hornyak Created Date: 5/28/1995 4:20:00 PM Document presentation ...

| PowerPoint PPT presentation | free to view

Virtual Screening with Topomer CoMFA PowerPoint PPT Presentation

Virtual Screening with Topomer CoMFA - ... define and claim island 'Lead Hopping' = find another island ' ... Lipha (seven lead hop trials, five successes) LeadQuest screening (partially disclosable) ...

... define and claim island 'Lead Hopping' = find another island ' ... Lipha (seven lead hop trials, five successes) LeadQuest screening (partially disclosable) ...

| PowerPoint PPT presentation | free to view

Geen diatitel PowerPoint PPT Presentation

Geen diatitel - aMerck Lipha, data on file; bDeFronzo & Goodman (1995); cWolffenbuttel et al (2000) ... in the post-sulphonylurea study. HbA1C response in metformin failures ...

aMerck Lipha, data on file; bDeFronzo & Goodman (1995); cWolffenbuttel et al (2000) ... in the post-sulphonylurea study. HbA1C response in metformin failures ...

| PowerPoint PPT presentation | free to view

La Gestion de Portefeuille de Projets (PPM) PowerPoint PPT Presentation

La Gestion de Portefeuille de Projets (PPM) - Title: Renaud Langlois Author: Renaud Langlois Last modified by: XP Created Date: 3/2/2006 10:42:24 PM Document presentation format: Affichage l' cran

Title: Renaud Langlois Author: Renaud Langlois Last modified by: XP Created Date: 3/2/2006 10:42:24 PM Document presentation format: Affichage l' cran

| PowerPoint PPT presentation | free to download

Diapositive 1 PowerPoint PPT Presentation

Diapositive 1 - Analyse de l volution de la prescription des antihypertenseurs du syst me r nine angiotensine : IEC / Sartans / Inhibiteur de la r nine

Analyse de l volution de la prescription des antihypertenseurs du syst me r nine angiotensine : IEC / Sartans / Inhibiteur de la r nine

| PowerPoint PPT presentation | free to download

TYPE 2 DIABETES MELLITUS PowerPoint PPT Presentation

TYPE 2 DIABETES MELLITUS - TYPE 2 DIABETES MELLITUS Richard Sachson MD DIABETES AND GESTATIONAL DIABETES AMONG ADULTS IN THE U.S. -2001 Diabetes and Obesity: The Continuing Epidemic ...

TYPE 2 DIABETES MELLITUS Richard Sachson MD DIABETES AND GESTATIONAL DIABETES AMONG ADULTS IN THE U.S. -2001 Diabetes and Obesity: The Continuing Epidemic ...

| PowerPoint PPT presentation | free to download

A Global Profile - To Help our customers to achieve its strategic objectives, ... Agora Gazeta. E Wedel. Huta Czestochova. Zaclady Kuznicze. Tabuk Pharmaceuticals. Jordan Telecom ...

To Help our customers to achieve its strategic objectives, ... Agora Gazeta. E Wedel. Huta Czestochova. Zaclady Kuznicze. Tabuk Pharmaceuticals. Jordan Telecom ...

| PowerPoint PPT presentation | free to download

TYPE 2 DIABETES MELLITUS PowerPoint PPT Presentation

TYPE 2 DIABETES MELLITUS - Richard Sachson MD Diabetes: 16 Million and Climbing Estimated 10.3 million diagnosed + 5.4 million undiagnosed cases Type 2 diabetes accounts for 90-95% of cases ...

Richard Sachson MD Diabetes: 16 Million and Climbing Estimated 10.3 million diagnosed + 5.4 million undiagnosed cases Type 2 diabetes accounts for 90-95% of cases ...

| PowerPoint PPT presentation | free to download

Les multithrapies du patient polyvasculaire les traitements vise mtabolique: de la biochimie la paro PowerPoint PPT Presentation

Les multithrapies du patient polyvasculaire les traitements vise mtabolique: de la biochimie la paro - n 'apportent pas le b n fice escompt . Induisent un mal fice. HCL/UCBL ... n 'apportent pas le b n fice escompt . fibrates ? Induisent un mal fice. Inhibiteurs cetp ...

n 'apportent pas le b n fice escompt . Induisent un mal fice. HCL/UCBL ... n 'apportent pas le b n fice escompt . fibrates ? Induisent un mal fice. Inhibiteurs cetp ...

| PowerPoint PPT presentation | free to view